Display options
Share it on

Clin Transl Med. 2012 Aug 14;1(1):15. doi: 10.1186/2001-1326-1-15.

The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM).

Clinical and translational medicine

Xiaoming Chen, Roland Andersson, William Cs Cho, David Christiani, Richard Coico, Jeffery Drazen, Markus Ege, Thomas Fehniger, Hongwei Gao, Kunlin Jin, Michael N Liebman, Elena Lopez, Giuseppe Marraro, Gyorgy Marko-Varga, Francesco M Marincola, Laurentiu M Popescu, Claudio Spada, Aamir Shahzad, Ena Wang, Wei Wang, Xiangdong Wang, Yong-Xiao Wang, Jinglin Xia, Jia Qu

Affiliations

  1. Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Center for Human Immunology (CHI), NIH, Bethesda MD, USA. [email protected].

PMID: 23369397 PMCID: PMC3561055 DOI: 10.1186/2001-1326-1-15

Abstract

BACKGROUND: Supported by the International Society for Translational Medicine (ISTM), Wenzhou Medical College and the First Affiliated Hospital of Wenzhou Medical College, the International Conference on Translational Medicine (ICTM) was held on October 22-23, 2011 in Wenzhou, China. Nearly 800 registrants attended the meeting, primarily representing institutes and hospitals in Europe, The United States of America, And Asia, and China. The meeting was chaired and organized by Dr. Xiangdong Wang, Xiaoming Chen, Richard Coico, Jeffrey M. Drazen, Richard Horton, Francesco M. Marincola, Laurentiu M. Popescu, Jia Qu and Aamir Shahzad.

FINDINGS: The meeting focused on the communication of the need to foster translational medicine (TM) by building and broadening bridges between basic research and clinical studies at the international level. The meeting included distinguished TM experts from academia, the pharmaceutical and diagnostics industries, government agencies, regulators, and clinicians and provided the opportunity to identify shared interests and efforts for collaborative approaches utilizing cutting edge technologies, innovative approaches and novel therapeutic interventions. The meeting defined the concept of TM in its two-way operational scheme and emphasized the need for bed to bench efforts based directly on clinical observation.

CONCLUSIONS: It was the meeting participants' realization that the shared main goals of TM include breaking the separation between clinic practice and basic research, establishing positive feedback by understanding the basis of expected and unexpected clinical outcomes and accelerating basic research relevant to human suffering. The primary objectives of the meeting were two-fold: to accelerate the two-way translation by informing the participants representing the different disciplines about the state of art activities around TM approaches; and to identify areas that need to be supported by redirecting limited resources as well as identifying new sources of funding. This report summarizes key concepts presented during the meeting representing the state-of-art translational research and salient aspects of the ensuing discussions.

References

  1. J Cardiovasc Pharmacol. 2011 Jan;57(1):8-12 - PubMed
  2. Stroke. 2001 Jun;32(6):1349-59 - PubMed
  3. Circ Res. 2007 Jun 8;100(11):1579-88 - PubMed
  4. N Engl J Med. 2010 Sep 23;363(13):1211-1221 - PubMed
  5. Expert Opin Ther Targets. 2012 Jan;16(1):1-3 - PubMed
  6. Nat Rev Immunol. 2008 Mar;8(3):169-82 - PubMed
  7. Protein Expr Purif. 2005 Jul;42(1):7-11 - PubMed
  8. Science. 2008 Sep 5;321(5894):1298-9 - PubMed
  9. Curr Opin Mol Ther. 2009 Dec;11(6):641-51 - PubMed
  10. Toxicol Lett. 2007 Apr 25;170(2):146-56 - PubMed
  11. PLoS One. 2011;6(6):e20669 - PubMed
  12. Clin Sci (Lond). 2010 Apr 20;119(2):87-95 - PubMed
  13. Front Genet. 2011 Feb 28;2:7 - PubMed
  14. J Allergy Clin Immunol. 2011 Jan;127(1):138-44, 144.e1-4 - PubMed
  15. J Transl Med. 2004 Jan 31;2(1):5 - PubMed
  16. J Clin Bioinforma. 2011 Oct 03;1:26 - PubMed
  17. Nature. 2008 Apr 3;452(7187):633-7 - PubMed
  18. Clin Biochem. 2003 Feb;36(1):2-7 - PubMed
  19. J Urban Health. 2012 Apr;89(2):329-38 - PubMed
  20. Expert Rev Proteomics. 2011 Feb;8(1):1-4 - PubMed
  21. Protein Pept Lett. 2006;13(8):785-92 - PubMed
  22. Curr Treat Options Oncol. 2011 Jun;12(2):111-25 - PubMed
  23. Thorax. 1998 Mar;53(3):204-12 - PubMed
  24. Am J Med. 2003 Apr 15;114(6):477-84 - PubMed
  25. Br J Surg. 2011 Aug;98(8):1041-55 - PubMed
  26. J Proteome Res. 2011 Jan 7;10(1):3 - PubMed
  27. Biomed Mass Spectrom. 1984 Nov;11(11):601 - PubMed
  28. Anal Chem. 2011 Nov 1;83(21):8329-36 - PubMed
  29. Br J Cancer. 2005 Aug 22;93(4):387-91 - PubMed
  30. J Clin Bioinforma. 2011 Sep 16;1(1):24 - PubMed
  31. J Epidemiol. 2009;19(6):333-41 - PubMed
  32. J Proteome Res. 2011 Nov 4;10(11):4959-69 - PubMed
  33. J Transl Med. 2012 Mar 27;10:61 - PubMed
  34. RNA Biol. 2011 Jan-Feb;8(1):125-31 - PubMed
  35. J Clin Bioinforma. 2011 Jul 06;1(1):16 - PubMed

Publication Types

Grant support